Etiology of senile osteoporosis: A hypothesis

Clinical Orthopaedics and Related Research

Volumn 443, Issue , 2006, Pages 25-27

  Atik, O Sahap ^a,d   Uslu, M Murad ^b   Eksioglu, Fatih ^b   Satana, Tolgay ^c  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

^c MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^d NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PARATHYROID HORMONE; PROSTAGLANDIN E2; BIOLOGICAL MARKER; PROSTAGLANDIN; ZINC;

CONFERENCE PAPER; DIET SUPPLEMENTATION; HUMAN; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; SENILE OSTEOPOROSIS; ZINC DEFICIENCY; AGE; AGED; BLOOD; REVIEW; RISK FACTOR;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; HEPARIN; HUMANS; OSTEOPOROSIS; PROSTAGLANDINS; RISK FACTORS; ZINC;

EID: 33645279044     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000200235.76565.c8     Document Type: Conference Paper

References (24)

1. Alffram PA. An epidemiological study of cervical and trochanteric fractures of the femur in an urban population: Analysis of 1664 cases with special reference to etiologic factors. Acta Orthop Scand. 1964;65(Suppl):1-109.
2. Atik OS. Zinc and senile osteoporosis. J Am Geriatr Soc. 1983;31:790-791.
3. Atik OS, Bor N, Kutkam T, Gogus T. Heparin secreted marrow mast cells and osteoporosis. Hac Bull Med Surg. 1979;12:19-24.
4. Atik OS, Surat A, Gogus T. Prostaglandin E2-like activity and senile osteoporosis. Prostaglandins Leukot Med. 1983;11:105-107.
5. Bor NM, Oner G, Noyan A, Arcasoy A, Cavdar A, Sozer S. Relation between mast cells and serum zinc levels. New Istanbul Contrib Clin Sci. 1976;11:136-141.
6. 65Zn in fractured bones. Lancet. 1968;292:682.
7. Campion JM, Maricic MJ. Osteoporosis in men. Am Fam Physician. 2003;67:1521-1526.
8. Elmståhl S, Gullberg B, Janzon L, Johnell O, Elmstahl B. Increased incidence of fractures in middle-aged and elderly men with low intakes of phosphorus and zinc. Osteoporos Int. 1998;8:333-340.
9. Goldhaber P. Heparin enhancement of factors stimulating bone resorption in tissue culture. Science. 1965;147:407-408.
10. Haumont S. Distribution of zinc in bone tissue. J Histochem Cytochem. 1961;9:141-145.
11. Hyun TH, Barrett-Connor E, Milne DB. Zinc intakes and plasma concentrations in men with osteoporosis: the Rancho Bernardo Study. Am J Clin Nutr. 2004;80:715-721.
12. Kishi S, Yamaguchi M. Inhibitory effect of zinc compounds on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol. 1994;48:1225-1230.
13. Klein DC, Raisz LG. Prostaglandins: Stimulation of bone resorption in tissue culture. Endocrinology. 1970;86:1436-1440.
14. Moonga BS, Dempster DW. Zinc is a potent inhibitor of osteoclastic bone resorption in vitro. J Bone Miner Res. 1995;10:453-457.
15. Raisz LG. Prostaglandins and the hypercalcemia of cancer. N Engl J Med. 1973;289:214-215.
16. Raisz LG. Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J Nutr. 1995;125(Suppl):2024-2027.
17. Relea P, Revilla M, Ripoll E, Arribas I, Villa LF, Rico H. Zinc, biochemical markers of nutrition and type I osteoporosis. Age Aging. 1995;24:303-307.
18. Sackler JP, Liu L. Heparin induced osteoporosis. Br Radiol. 1973;46:548-550.
19. Squires JW, Pinch LW. Heparin induced spinal fractures. JAMA. 1979;241:2417-2418.
20. Tashjian AH Jr, Voelkel EF, Levine L, Goldhaber P. Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E2: A new model for the hypercalcemia of cancer. J Exp Med. 1972;136:1329-1343.
21. Vanderwiel CJ, Talmage RV. Comparison of the effects of prostaglandin E2 and parathyroid hormone on plasma calcium concentration and osteoclast function. Endocrinology. 1979;105:588-594.
22. Vrotsos Y, Miller SC, Marks SC Jr. Prostaglandin E2: A powerful anabolic agent for generalized or site-specific bone formation. Crit Rev Eukaryot Gene Expr. 2003;13:255-263.
23. Yamaguchi M, Segawa Y, Shimokawa N, Tsuzuike N, Tagashira E. Inhibitory effect of β-alanyl-L-histidinato zinc on bone resorption in tissue culture. Pharmacology. 1992;45:292-300.
24. Yoneda T, Mundy GR. Prostaglandins are necessary for osteoclast- activating factor production by activated peripheral blood leukocytes. J Exp Med. 1979;149:279-283.